CD70 and non-Hodgkin lymphoma: There are a number of ongoing clinical trials of CAR-T cell therapy targeting BAFFR receptors in patients with r/r B-cell NHL (NCT05370430) and CD70 in patients with CD70-positive malignant hematological diseases, including patients with NHL (NCT04662294).